Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
about
Autoimmune liver serology: current diagnostic and clinical challengesAutoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the diseaseDrug hypersensitivity reactions targeting the skin in dogs and catsAnti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNAAutoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristicsDetection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitisIdiosyncratic drug reactions: a mechanistic evaluation of risk factorsDrug bioactivation, covalent binding to target proteins and toxicity relevance.Role of metabolism in drug-induced idiosyncratic hepatotoxicity.Cytochrome P450s and other enzymes in drug metabolism and toxicity.Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.Mechanisms of drug toxicity and relevance to pharmaceutical development.Drug-induced autoimmune-like hepatitis.Central role of mitochondria in drug-induced liver injury.Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?CYP2E1 autoantibodies in liver diseasesTransitioning from Idiopathic to Explainable Autoimmune Hepatitis.An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.Possible role of cytochromes P450 in lupus erythematosus and related disorders.Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity.Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury.Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment.Viral induction of autoimmunity: mechanisms and examples in hepatology.Immunogenicity studies of a synthetic antigen of alpha methyl dopa.Conservation of a functionally important surface region between two families of the cytochrome P-450 superfamily.Genotoxic bioactivation of constituents of a diesel exhaust particle extract by the human lung.Use of molecular simulation for mapping conformational CYP2E1 epitopes.Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis?Molecular Basis for the Transport of Cytochrome P450 2E1 to the Plasma MembraneCytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease
P2860
Q24644140-27CA7284-9307-4B01-BDB9-27E090EB929DQ24804699-47671E87-E51A-412F-A36E-7D77721EFF5AQ26822023-E2D5C4E7-6B99-40B3-8FC2-3D7F7FB18962Q27473555-4682D4EB-2625-4094-B9B3-F2B2F3E9456EQ28087726-FF45A389-1746-4458-B318-74E4241377C9Q28378764-3B0887AE-D572-41F5-9516-D5CEED7487BCQ34403403-55D78D9D-C3E8-473B-9590-A99C3F16E506Q36061821-85D2B22F-DB97-46AD-A67F-E33A56A28CEBQ36179528-70857BCF-716B-4670-AA4E-40D05DE0AFCAQ36439150-28ADCB7F-756E-4E33-BC77-1ACF2DC366E7Q36871056-52B089F5-FA27-4E8E-BE43-B9496700A99CQ37360013-685B555F-21AD-4C07-9B7D-6A09DC4C93D2Q37803316-387D9FF5-83D7-4CA5-BD84-38E5B60874BAQ37843783-9AE537ED-D84C-41C7-8430-C3A18F3BB9F4Q37926590-CEAB2034-D6E3-4E87-82C8-1FDD1BE65CD6Q38177342-340731F1-6869-4BFD-8C9A-F54C1BF17176Q38280871-6B4394A8-6D39-401A-8E83-823ED9B16FFAQ38496935-9635B818-4469-460A-882F-E2A233DFD126Q40373033-7C5B0AF0-09E4-4C77-8903-26A0BF12D815Q40498843-2844BFF6-F213-4AF4-8A1E-EDA69EF9122FQ40737853-9B5B3A83-5820-4B16-866F-76F1E8BB7A26Q40817414-3BFACCA1-3AE4-4FF8-A426-D0046E894BBEQ41355985-D7927574-AA3B-4382-B8D3-5BC25DE54008Q41681581-AD4BF230-62D4-4025-A2C9-6E67C7504ABCQ42287517-ABFF9C57-612B-4F0C-A691-EC0201209D91Q42810290-199F0E9A-6F51-45B0-99A9-6B0422FD2DBEQ43426007-FB972E80-15F7-4D5F-83F2-CC8980948308Q45084887-17023674-58B1-4950-BEAC-7E723B6CB3D7Q47116300-CACCD1D5-706B-4F9C-A57B-416087DCE6CCQ57371875-22A35E1A-C9C7-48FE-BF7F-07FFA09DD69AQ57734349-04CA0411-0A4A-4734-94E7-9066EA424C11
P2860
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@ast
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@en
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@nl
type
label
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@ast
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@en
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@nl
prefLabel
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@ast
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@en
Anti-liver endoplasmic reticul ...... hydralazine-induced hepatitis.
@nl
P2093
P2860
P356
P1476
Anti-liver endoplasmic reticul ...... ihydralazine-induced hepatitis
@en
P2093
D Pessayre
F P Guengerich
P2860
P304
P356
10.1172/JCI114660
P407
P577
1990-06-01T00:00:00Z